Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
BioCorRx Inc. develops and provides addiction treatment solutions focused on substance use disorders, including alcoholism and opioid addiction. Its core offerings include the BioCorRx® Recovery Program, combining cognitive behavioral therapy and medication-assisted treatment, and the UnCraveRx® Weight Loss Program. Through its subsidiary BioCorRx Pharmaceuticals, the company develops implantable naltrexone pellets for long-acting treatment. It serves healthcare providers and patients, leveraging proprietary therapies and pharmaceutical innovations in addiction and weight management.
This description was generated via AI from an annual report. Updated about 1 year ago.